Related Experiment Videos
Choline: binding studies provide some evidence for a weak, direct agonist action in brain
Molecular Pharmacology
|November 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Autoradiographic Determination of Neurotransmitter Receptor Distributions in the Cerebral and Cerebellar Cortices 1 , 2.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·2017
Functional and expression analysis of the metal-inducible dmeRF system from Rhizobium leguminosarum bv. viciae.
Applied and environmental microbiology·2013
Florfenicol feed supplemented decrease the clinical effects of Mycoplasma hyopneumoniae experimental infection in swine in México.
Research in veterinary science·2011
Anchored kinase and phosphatase signaling networks in amyloid β-induced synaptic dysfunction.
Molecular pharmacology·2026
Where are peptide ligands of potassium channels sourced from?
Molecular pharmacology·2026
Regulation of organic anion transporting polypeptide 1B1 transport function by lysine deacetylase 6.
Molecular pharmacology·2026
Emerging roles of platelet DNA in cancer detection and noninvasive prenatal testing.
Molecular pharmacology·2026
Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.
Journal of pharmaceutical analysis·2026
Structure-informed characterization of a TLR2-binding scFv reveals a CDR-centered recognition model.
Biochemical and biophysical research communications·2026
Safety assessment of the substance 1,3-benzenedicarboxamide, 5-[[[cis-4-(1,1-dimethylethyl)cyclohexyl]carbonyl]amino]-N1,N3-bis[cis-4-(1-methylethyl)cyclohexyl]- for use in food contact materials.
EFSA journal. European Food Safety Authority·2026
Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.
Naunyn-Schmiedeberg's archives of pharmacology·2026
New paradigm of q-CAR drug development targeting disease-specific protein conformations.
npj drug discovery·2026